Ketotifen Ud Stulln (Ketotifen)

Ketotifen works as a dual‑action agent: it blocks H1 histamine receptors, preventing histamine‑mediated itching and redness, and it stabilises mast cells, inhibiting the release of inflammatory mediators like leukotrienes and prostaglandins. This combined effect reduces both immediate and delayed allergic eye reactions.

The appropriate dose of Ketotifen Ud Stulln is determined by the prescribing healthcare professional based on the severity of the eye allergy, patient age, and response to therapy. No fixed regimen is provided here; the prescriber will specify the number of drops and frequency.

Safety data for ketotifen ophthalmic use during pregnancy or lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Patients should discuss their situation with a qualified healthcare provider before starting treatment.

To order Ketotifen Ud Stulln, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Ketotifen is comparable to other ocular antihistamine/mast‑cell stabilisers such as olopatadine. Both reduce allergic eye symptoms, but ketotifen has a longer history of use and may cause a transient stinging sensation on instillation. Choice between them often depends on patient tolerance, physician preference and local availability.

Ketotifen Ud Stulln should be stored below 25 °C, protected from light and moisture, and kept in its original container. Do not freeze the product. Ensure the dropper tip remains clean and avoid contaminating the solution. Follow any additional instructions on the label.

The product is applied as eye drops. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place the prescribed number of drops into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption, and contact lenses should be removed before use.

Serious risks include severe allergic reactions such as anaphylaxis, persistent eye pain, corneal ulceration, significant visual loss, and acute angle‑closure glaucoma. If any of these occur, the medication should be discontinued immediately and medical attention sought.

Ketotifen Ud Stulln should not be used by individuals with known hypersensitivity to ketotifen or any component of the formulation. Patients with severe ocular conditions such as active infections, corneal ulcers, or uncontrolled glaucoma should avoid its use until evaluated by an eye care professional.